Related Experiment Video

Updated: Jun 10, 2026

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical

Eudocia C Quant1, Patrick Y Wen

  • 1Division of Cancer Neurology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, 44 Binney Street, SW 430D, Boston, MA 02115, USA.

Neuroimaging Clinics of North America
|August 17, 2010
PubMed

Insights

New targeted therapies offer hope for glioblastoma patients, addressing the poor prognosis despite standard treatments. Research into molecular pathways is driving the development of novel agents to improve survival and quality of life.

Area of Science:

  • Neuro-oncology
  • Molecular biology
  • Pharmacology

Background:

  • Glioblastoma (GBM) has a poor prognosis despite standard treatments like surgery, radiation, and chemotherapy.
  • There is a critical need for novel therapeutic strategies to improve patient survival and quality of life.
  • Advances in understanding gliomagenesis and disease progression have identified key molecular targets.

Purpose of the Study:

  • To review novel therapeutic agents for glioblastoma.
  • To emphasize targeted therapies based on molecular pathways.
  • To highlight recent advancements in glioblastoma treatment strategies.

Main Methods:

  • Literature review of novel glioblastoma therapies.
  • Focus on targeted agents against specific molecular pathways.
  • Analysis of research on receptor tyrosine kinases, signaling molecules, epigenetics, and tumor microenvironment.

Main Results:

  • Novel agents targeting key molecular pathways are under development.
  • Targeted therapies aim to inhibit receptor tyrosine kinases and intracellular signaling.
  • Strategies also focus on epigenetic modifications and the tumor microenvironment.

Conclusions:

  • Targeted agents represent a promising avenue for glioblastoma treatment.
  • Further research and clinical trials are essential to validate novel therapies.
  • Improving glioblastoma outcomes requires innovative therapeutic approaches.

More Related Videos

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations04:46

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...